10-49107675-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001031746.5(VSTM4):c.376G>A(p.Val126Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000135 in 1,614,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001031746.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSTM4 | NM_001031746.5 | c.376G>A | p.Val126Ile | missense_variant | 2/8 | ENST00000332853.9 | NP_001026916.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSTM4 | ENST00000332853.9 | c.376G>A | p.Val126Ile | missense_variant | 2/8 | 1 | NM_001031746.5 | ENSP00000331062 | P1 | |
VSTM4 | ENST00000298454.3 | c.376G>A | p.Val126Ile | missense_variant | 2/3 | 2 | ENSP00000298454 |
Frequencies
GnomAD3 genomes AF: 0.000657 AC: 100AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251470Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135908
GnomAD4 exome AF: 0.0000807 AC: 118AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000701 AC XY: 51AN XY: 727242
GnomAD4 genome AF: 0.000656 AC: 100AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.000712 AC XY: 53AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.376G>A (p.V126I) alteration is located in exon 2 (coding exon 2) of the VSTM4 gene. This alteration results from a G to A substitution at nucleotide position 376, causing the valine (V) at amino acid position 126 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at